It is observed that there also exists HER2 expression in HER2-negative tumors, but in smaller levels (HER2-low status), which might be different from HER2-zero and HER2-positive breast cancer in treatment pattern and prognosis. This evidence concerns the gene ERBB2 and breast carcinoma.